GRPR Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of GRPR Antibodies for advanced research in cancer biology and neurobiology. GRPR Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Gastrin-releasing peptide receptor (GRPR) plays a crucial role in mediating the effects of gastrin-releasing peptide, which is involved in various physiological processes, including the regulation of gastrointestinal function and modulation of neurogenic inflammation. GRPR is implicated in the progression of certain cancers, making it a significant target for therapeutic interventions and diagnostic applications. Understanding GRPR function is essential for developing strategies to combat diseases associated with its dysregulation. Research applications include studying receptor expression patterns, signaling pathways, and protein-protein interactions. Investigating GRPR's role in tumor growth and metastasis can lead to new therapeutic approaches. GRPR monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of cancer biology and neurological disorders.